Orient EuroPharma Co., Ltd. logo

Orient EuroPharma Co., Ltd. (4120)

Market Closed
15 Oct, 05:30 AM
TWSE TWSE
NT$
45. 85
+0.85
+1.8889%
NT$
- Market Cap
- P/E Ratio
90% Div Yield
1,000 Volume
- Eps
NT$ 45
Previous Close
Add Transaction
Day Range
45.85 45.85
Year Range
42.6 50
Want to track 4120 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Orient EuroPharma Co., Ltd. (4120) Statistics

Valuation metrics

Market Cap -
Enterprise value 5.93B
Trailing P/E (ttm) -6.89
Forward P/E -
PEG ratio 0.11
Price/Sales (ttm) 0.85
Price/Book (mrq) 0.76
Enterprise Value/Revenue 1.28
Enterprise Value/EBITDA -40.87

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 13.44K
Average volume (90 days) 36.86K

Price summary

52-Week low 42.6
52-Week high 50
Beta -
50-Day moving average 46.18
200-Day moving average 46.55

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 4
Trailing annual dividend yield 0.0872%
5-Year annual dividend yield -
Payout ratio -0.16
Dividend Date 6 Aug 2026
Ex-Dividend Date 20 Jul 2026
Last split factor 1,160:1,000
Last split Date 28 Jul 2010

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.12%
Operating margin -0.07%

Operational effectiveness

Return on assets -0.05%
Return on equity -0.09%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 53.63
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -6.21
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 19.2
Total debt (mrq) -
Total Debt/Equity (mrq) 0.67
Current ratio (mrq) 1.16%
Book value per share (mrq) 73.07

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -